These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24624602)

  • 1. Partnership to decrease antipsychotic medication use in nursing homes: impact at the state level.
    Mort JR; Sailor R; Hintz L
    S D Med; 2014 Feb; 67(2):67-9. PubMed ID: 24624602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When nurses lead.
    Bonner A
    J Gerontol Nurs; 2014 Jun; 40(6):17-21. PubMed ID: 24800653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An observational study of antipsychotic medication use among long-stay nursing home residents without qualifying diagnoses.
    Phillips LJ; Birtley NM; Petroski GF; Siem C; Rantz M
    J Psychiatr Ment Health Nurs; 2018 Oct; 25(8):463-474. PubMed ID: 29911331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication prescribing in assisted living and nursing home residents with dementia after the National Partnership.
    Coe AB; Zhang T; Zullo AR; Gerlach LB; Thomas KS; Daiello LA; Varma H; Lo D; Joshi R; Shireman TI; Bynum JPW
    J Am Geriatr Soc; 2022 Dec; 70(12):3513-3525. PubMed ID: 35984088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care With the Use of Antipsychotics and Other Psychotropics in Long-term Care in the United States From 2009 to 2014.
    Maust DT; Kim HM; Chiang C; Kales HC
    JAMA Intern Med; 2018 May; 178(5):640-647. PubMed ID: 29550856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in antipsychotic treatment choice across US nursing homes.
    Huybrechts KF; Rothman KJ; Brookhart MA; Silliman RA; Crystal S; Gerhard T; Schneeweiss S
    J Clin Psychopharmacol; 2012 Feb; 32(1):11-7. PubMed ID: 22198446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Educating Nursing Home Staff in Dementia Sensitive Communication: Impact on Antipsychotic Medication Use.
    Shaw C; Williams KN; Perkhounkova Y
    J Am Med Dir Assoc; 2018 Dec; 19(12):1129-1132. PubMed ID: 30471803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving dementia care: new initiatives, new opportunities.
    Martin CM
    Consult Pharm; 2014 Jan; 29(1):16-23. PubMed ID: 24413011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Off-label use of second-generation antipsychotic agents among elderly nursing home residents.
    Kamble P; Sherer J; Chen H; Aparasu R
    Psychiatr Serv; 2010 Feb; 61(2):130-6. PubMed ID: 20123817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency Citations on Inappropriate Psychotropics Use Related to Care for Behavioral Symptoms of Dementia.
    Yoon JM; Trinkoff AM; Galik E; Storr CL; Lerner NB; Brandt N; Zhu S
    J Am Med Dir Assoc; 2022 Nov; 23(11):1772-1779. PubMed ID: 35568094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMS Strategies To Reduce Antipsychotic Drug Use In Nursing Home Patients With Dementia Show Some Progress.
    Lucas JA; Bowblis JR
    Health Aff (Millwood); 2017 Jul; 36(7):1299-1308. PubMed ID: 28679818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
    Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic use and the risk of diabetes in nursing home residents with dementia.
    Jalbert JJ; Daiello LA; Eaton CB; Miller SC; Lapane KL
    Am J Geriatr Pharmacother; 2011 Jun; 9(3):153-63. PubMed ID: 21596626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing approaches and barriers to reduce antipsychotic drug use in Florida nursing homes.
    Ellis ML; Molinari V; Dobbs D; Smith K; Hyer K
    Aging Ment Health; 2015; 19(6):507-16. PubMed ID: 25166458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Antipsychotic Reduction Efforts in Patients With Dementia in Veterans Health Administration Nursing Homes.
    Gerlach LB; Maust DT; Kales HC; Chang M; Kim HM; Wiechers IR; Zivin K
    Am J Psychiatry; 2022 Aug; 179(8):544-552. PubMed ID: 35615813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotics and dementia: a time for restraint?
    Morley JE
    J Am Med Dir Assoc; 2012 Nov; 13(9):761-3. PubMed ID: 23062622
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychopharmacological medication use among older adults with dementia in nursing homes.
    Brandt NJ; Pythtila J
    J Gerontol Nurs; 2013 Apr; 39(4):8-14. PubMed ID: 23616986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication use patterns in elderly South Dakota Medicare patients.
    Mort JR; Schroeder SD; Sailor R
    S D Med; 2010 Feb; 63(2):47-9. PubMed ID: 20302063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in antipsychotic prescribing among long-term care residents receiving hospice care.
    Gerlach LB; Fashaw S; Strominger J; Ogarek J; Zullo AR; Daiello LA; Teno J; Shireman TI; Bynum JPW
    J Am Geriatr Soc; 2021 Aug; 69(8):2152-2162. PubMed ID: 33837537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving Nursing Home Compliance via Revised Antipsychotic Use Survey Tool.
    Bach LL; Lazzaretto DL; Young CF; Lofholm PW
    Consult Pharm; 2017 Apr; 32(4):228-238. PubMed ID: 28376988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.